Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Assembly Biosciences (ASMB)

Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Assembly Biosciences: Q1 Earnings Snapshot

Assembly Biosciences: Q1 Earnings Snapshot

ASMB : 15.39 (+1.72%)
Assembly Biosciences: Q3 Earnings Snapshot

Assembly Biosciences: Q3 Earnings Snapshot

ASMB : 15.39 (+1.72%)
Assembly Biosciences: Q2 Earnings Snapshot

Assembly Biosciences: Q2 Earnings Snapshot

ASMB : 15.39 (+1.72%)
Assembly Biosciences: Q1 Earnings Snapshot

Assembly Biosciences: Q1 Earnings Snapshot

ASMB : 15.39 (+1.72%)
Carver Biosciences Announces Appointment of Three Members to its Scientific Advisory Board

Carver Biosciences, Inc., a biotech company focused on the development of CRISPR/Cas13 antivirals, today announced the formation of its Scientific Advisory Board (SAB). Cameron Myhrvold Ph.D., co-founder...

ASMB : 15.39 (+1.72%)
PRDS : 2.16 (unch)
TEVA Shares Rise on Broad Support for Opioids Settlement

With the required participation from states and local governments, TEVA can now move forward with the nationwide settlement.

RDY : 71.85 (-1.13%)
TEVA : 17.16 (-1.38%)
ACST : 3.23 (-0.28%)
ASMB : 15.39 (+1.72%)
After Plunging 17% in 4 Weeks, Here's Why the Trend Might Reverse for Assembly Biosciences (ASMB)

The heavy selling pressure might have exhausted for Assembly Biosciences (ASMB) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street...

ASMB : 15.39 (+1.72%)
Assembly Biosciences: Q3 Earnings Snapshot

Assembly Biosciences: Q3 Earnings Snapshot

ASMB : 15.39 (+1.72%)
Assembly Biosciences Reports Second Quarter 2022 Financial Results and Recent Highlights

SOUTH SAN FRANCISCO, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company...

ASMB : 15.39 (+1.72%)
Assembly Biosciences (ASMB) Upgraded to Strong Buy: Here's Why

Assembly Biosciences (ASMB) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

ASMB : 15.39 (+1.72%)

Barchart Exclusives

3 Highest-yielding Tech Stocks to Buy Now
Tech stocks aren't famous for paying dividends. There are, however, a select few that do. Here are the top 3 based on yield. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar